Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Zalata

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Andrologia|March 6, 2009
Bilateral testicular tuberculomas: a case detectionA Hassan, S El-Mogy, K Zalata, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 3, 2009
Progressive stridor: could it be a congenital cystic lung disease?M Zedan, M A Elgamal, K Zalata, et al.
Leukemia & Lymphoma|May 27, 2004
The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcomeS Aref, M Mabed, K Zalata, et al.
Journal of Viral Hepatitis|June 9, 2012
Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progressionG Esmat, M El-Bendary, S Zakarya, et al.
Hematology (Amsterdam, Netherlands)|May 15, 2003
c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphomaS Aref, M Fouda, E El-Dosoky, et al.
Hepatology International|April 21, 2017
A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis CG Shiha, S Seif, A Eldesoky, et al.
Gut|March 16, 2007
Non-alcoholic fatty liver disease in patients with HCV genotype 4A El-Zayadi, M Attia, E M F Barakat, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 22, 2009
Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight lossG Esmat, Wafaa El Akel, M Metwally, et al.
British Journal of Biomedical Science|February 1, 2019
Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver diseaseH Elalfy, M A El-Maksoud, S Abed, et al.
Journal of Viral Hepatitis|July 31, 2014
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in EgyptP Bonnard, A Elsharkawy, K Zalata, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Andrologia|March 6, 2009
Bilateral testicular tuberculomas: a case detectionA Hassan, S El-Mogy, K Zalata, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 3, 2009
Progressive stridor: could it be a congenital cystic lung disease?M Zedan, M A Elgamal, K Zalata, et al.
Leukemia & Lymphoma|May 27, 2004
The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcomeS Aref, M Mabed, K Zalata, et al.
Journal of Viral Hepatitis|June 9, 2012
Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progressionG Esmat, M El-Bendary, S Zakarya, et al.
Hematology (Amsterdam, Netherlands)|May 15, 2003
c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphomaS Aref, M Fouda, E El-Dosoky, et al.
Hepatology International|April 21, 2017
A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis CG Shiha, S Seif, A Eldesoky, et al.
Gut|March 16, 2007
Non-alcoholic fatty liver disease in patients with HCV genotype 4A El-Zayadi, M Attia, E M F Barakat, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 22, 2009
Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight lossG Esmat, Wafaa El Akel, M Metwally, et al.
British Journal of Biomedical Science|February 1, 2019
Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver diseaseH Elalfy, M A El-Maksoud, S Abed, et al.
Journal of Viral Hepatitis|July 31, 2014
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in EgyptP Bonnard, A Elsharkawy, K Zalata, et al.
Pageof 2